APA Offers Assistance as FDA Asserts Regulatory Authority Over Tobacco

FDA was given regulatory authority over tobacco with the signing of the Family Smoking Prevention and Tobacco Control Act into law. Many APA scientists and GRO staff have been fighting to restrict the sale and distribution of cigarettes and smokeless tobacco products, but with this change, the biggest challenges may lie ahead, as the legislation calls for the establishment of a Center for Tobacco Products within FDA and the formation of Tobacco Products Scientific Advisory Committee.
On June 22, President Obama provided the Food and Drug Administration (FDA) with regulatory authority over tobacco by signing the Family Smoking Prevention and Tobacco Control Act into law. Many APA scientists and GRO staff have worked collaboratively on tobacco control issues over the years, including extensive comments (PDF, 561.4KB) in 1995 on the proposed rule to restrict the sale and distribution of cigarettes and smokeless tobacco products. The biggest challenges may lie ahead, however, as the legislation calls for the establishment of a Center for Tobacco Products within FDA and the formation of Tobacco Products Scientific Advisory Committee. In July, Science GRO staff drafted a letter of introduction (PDF, 32.4KB) to FDA Commissioner Hamburg providing background on APA’s efforts and offering to serve as a scientific resource as FDA moves forward to implement the new law.